GTG - Genetic Technologies Limited
ASX
->
Healthcare
->
Diagnostics & Research
Fitzroy,
Australia
Type: Equity
GTG price evolution
GTG
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3.73 | $3.73 | $7.85 | $7.85 |
| Short term investments | $0.02 | $0.02 | ||
| Net receivables | $1.12 | $1.12 | $1.92 | $1.92 |
| Inventory | $0.4 | $0.4 | $0.33 | $0.33 |
| Total current assets | $5.72 | $5.72 | $10.5 | $10.5 |
| Long term investments | ||||
| Property, plant & equipment | $0.43 | $0.43 | $0.6 | $0.6 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $8.47 | $8.47 | $14.86 | $14.86 |
| Current liabilities | ||||
| Accounts payable | $1.92 | $1.92 | $0.84 | $0.84 |
| Deferred revenue | ||||
| Short long term debt | $0.3 | $0.3 | $0.3 | $0.3 |
| Total current liabilities | $3.42 | $3.42 | $3.31 | $3.31 |
| Long term debt | $0.08 | $0.08 | $0.23 | $0.23 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $3.65 | $3.65 | $3.69 | $3.69 |
| Shareholders' equity | ||||
| Retained earnings | -$160.78 | -$160.78 | -$156.72 | -$156.72 |
| Other shareholder equity | $4.25 | $4.25 | $6.54 | $6.54 |
| Total shareholder equity | $4.81 | $4.81 | $11.16 | $11.16 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.85 | $11.73 | $20.9 | $28.42 |
| Short term investments | $0.02 | $0.01 | $0 | |
| Net receivables | $1.92 | $2.42 | $1.07 | $0.79 |
| Inventory | $0.33 | $0.4 | $0.08 | $0.09 |
| Total current assets | $10.5 | $14.72 | $22.24 | $15.19 |
| Long term investments | ||||
| Property, plant & equipment | $0.6 | $0.95 | $0.64 | $0.44 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14.86 | $20.8 | $22.97 | $15.63 |
| Current liabilities | ||||
| Accounts payable | $0.84 | $1.15 | $0.27 | |
| Deferred revenue | ||||
| Short long term debt | $0.3 | $0.26 | $0.18 | $0.24 |
| Total current liabilities | $3.31 | $3.81 | $1.41 | $1.4 |
| Long term debt | $0.23 | $0.39 | $0.02 | $0.24 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $3.69 | $4.37 | $1.44 | $1.64 |
| Shareholders' equity | ||||
| Retained earnings | -$156.72 | -$150.21 | -$132.04 | -$126.12 |
| Other shareholder equity | $6.54 | $11.5 | $11.03 | |
| Total shareholder equity | $11.16 | $16.43 | $21.53 | $13.99 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.48 | $2.48 | $2.69 | $2.69 |
| Cost of revenue | $0.88 | $0.88 | $1.09 | $1.09 |
| Gross Profit | $1.6 | $1.56 | $1.59 | $1.59 |
| Operating activities | ||||
| Research & development | $0.2 | $0.2 | $0.36 | $0.36 |
| Selling, general & administrative | $2.9 | $2.9 | $2.62 | $2.62 |
| Total operating expenses | $5.02 | $5.02 | $5.2 | $5.2 |
| Operating income | -$2.54 | -$2.54 | -$2.51 | -$2.51 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.01 | -$0.01 | ||
| Interest expense | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Net income | ||||
| Net income | -$3.21 | -$3.21 | -$3.15 | -$3.15 |
| Income (for common shares) | -$3.21 | -$3.21 | -$3.15 | -$3.15 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10.35 | $9.22 | $0.12 | $0.01 |
| Cost of revenue | $4.34 | $3.01 | $0.31 | $0.23 |
| Gross Profit | $6.01 | $6.2 | -$0.19 | -$0.22 |
| Operating activities | ||||
| Research & development | $1.28 | $0.71 | $3.11 | $2.48 |
| Selling, general & administrative | $10.8 | $10.31 | $5.26 | $4.66 |
| Total operating expenses | $20.76 | $16.76 | $7.18 | $6.29 |
| Operating income | -$10.42 | -$7.54 | -$7.06 | -$6.28 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$0.16 | -$0.03 | ||
| Interest expense | -$0.03 | -$0.01 | $0.02 | $0.04 |
| Net income | ||||
| Net income | -$11.75 | -$7.13 | -$7.08 | -$6.29 |
| Income (for common shares) | -$11.75 | -$7.13 | -$7.08 | -$6.29 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$3.21 | -$3.21 | -$3.15 | -$3.15 |
| Operating activities | ||||
| Depreciation | $0.14 | $0.14 | $0.1 | $0.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$2.01 | -$2.01 | -$1.8 | -$1.8 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0.01 | -$0.01 |
| Investments | ||||
| Total cash flows from investing | $0.04 | $0.04 | $0.05 | $0.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.59 | $3.59 | ||
| Net borrowings | -$0.09 | -$0.09 | -$0.09 | -$0.09 |
| Total cash flows from financing | -$0.09 | -$0.09 | $3.04 | $3.04 |
| Effect of exchange rate | $0.08 | $0.08 | ||
| Change in cash and equivalents | -$2.06 | -$2.06 | $1.4 | $1.4 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Net income | -$11.75 | -$7.13 | -$7.08 | -$6.29 |
| Operating activities | ||||
| Depreciation | $0.53 | $0.45 | $0.48 | $0.27 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$9.72 | -$5.66 | -$6.3 | -$5.71 |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.06 | -$0.75 | -$0.04 |
| Investments | ||||
| Total cash flows from investing | -$0.31 | -$3.46 | -$0.75 | $0.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.17 | $15.9 | $21.79 | |
| Net borrowings | -$0.34 | -$0.27 | -$0.24 | -$0.13 |
| Total cash flows from financing | $5.92 | -$0.28 | $13.69 | $18.36 |
| Effect of exchange rate | $0.16 | $0.36 | $0.01 | -$0.6 |
| Change in cash and equivalents | -$3.88 | -$9.17 | $6.69 | $12.08 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $10.34M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$12.72M |
| Revenue Q/Q | -0.40% |
| Revenue Y/Y | -14.83% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -109.04% |
| ROE | -159.30% |
| Debt/Equity | 0.33 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.67 |
| Quick ratio | 1.56 |